NOI.pdf
PDF 111 KB Posted
- Solicitation number
- FDANOI122157
About this file
This document is a Presolicitation Notice that announces the U.S. Food and Drug Administration's (FDA) intent to award a sole-source contract to The Ohio State University. The FDA requires access to demand and fill rate data from Group Purchasing Organizations (GPOs) covering over 12,000 brand, generic, and biosimilar products. The applicable NAICS code is 541715, Research and Development in the Physical, Engineering, and Life Sciences. The anticipated period of performance is a base period plus 4 option years. The government intends to solicit and negotiate directly with The Ohio State University, and no solicitation will be issued. However, any interested parties that believe they can meet the requirement may submit a statement of capabilities within 11 calendar days. The related federal contract opportunity is for "Foodborne Pathogens in Small Specialty Farming Produce and Transduction of Antimicrobial Resistance Genes in Agricultural Systems" and has a response date of 10AM EST on 04/15/2024.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
PRESOLICITATION NOTICE: INTENT TO AWARD A SOLE-SOURCE CONTRACT
INTENDED SOURCE: The Ohio State University – 1960 Kenny Road-Columbus, OH 43210-
ANTICIPATED PERIOD of PERFORMANCE: Base plus 4 options years
DESCRIPTION OF REQUIREMENT:
Pursuant to the authority of 41 USC 3304(a)(1), as implemented by Federal Acquisition Regulation (FAR) Subpart 6.302-1, the U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grant Services (OAGS) intends to award a sole source contract to The Ohio State University. FDA has a need to obtain access to demand and fill rate data. Group Purchasing Organizations (GPO) collect data that cover pricing and supply chain distribution unique to hospitals on over 12,000 brand, generic, and biosimilar products.
The applicable North American Industry Classification System (NAICS) code for this acquisition is 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) 11.
The Government intends to solicit and negotiate directly with The Ohio State University and no solicitation will be issued. This notice of intent is not a request for competitive proposals or quotations; however, if any interested party believes they can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities must be submitted in writing and must contain material in sufficient detail to allow the government to determine if the party can perform the requirement. A determination by the Government not to compete this proposed requirement based on responses to this notice is solely within the discretion of the Government.
All interested parties must express their interest and capabilities in writing via email to Telisha.Wilson@fda.hhs.gov within eleven (11) calendar days after the date of publication of this notice. No faxed documents will be accepted. If no responsive statements are received within eleven (11) calendar days, an award will subsequently be made to The Ohio State University.
This is a Federal contract opportunity; FDA-NOI-122157 for services at Food and Drug Administration Office of Acquisitions and Grants Services - Rockville, MD.
Response Date: April 15, 2024 by 10:00AM Eastern Time. Please email responses to Telisha Wilson at Telisha.wilson@fda.hhs.gov.
No phone calls or faxes will be accepted.
mailto:Telisha.wilson@fda.hhs.gov
File details come from the government source that posted it. Updated .